home / stock / meip / meip quote
Last: | $2.88 |
---|---|
Change Percent: | 2.49% |
Open: | $2.82 |
Close: | $2.81 |
High: | $2.8891 |
Low: | $2.82 |
Volume: | 6,531 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.88 | $2.82 | $2.81 | $2.8891 | $2.82 | 6,531 | 07-17-2024 |
$2.81 | $2.78 | $2.81 | $2.88 | $2.78 | 14,426 | 07-16-2024 |
$2.84 | $2.93 | $2.84 | $2.93 | $2.78 | 15,650 | 07-15-2024 |
$2.9 | $2.8344 | $2.9 | $2.9001 | $2.8344 | 15,228 | 07-12-2024 |
$2.82 | $2.78 | $2.82 | $2.83 | $2.78 | 7,682 | 07-11-2024 |
$2.79 | $2.78 | $2.79 | $2.815 | $2.78 | 10,111 | 07-10-2024 |
$2.81 | $2.82 | $2.81 | $2.84 | $2.78 | 7,819 | 07-09-2024 |
$2.82 | $2.7801 | $2.82 | $2.82 | $2.7801 | 4,818 | 07-08-2024 |
$2.8 | $2.81 | $2.8 | $2.83 | $2.78 | 11,485 | 07-05-2024 |
$2.82 | $2.825 | $2.82 | $2.825 | $2.8 | 1,672 | 07-04-2024 |
$2.82 | $2.825 | $2.82 | $2.825 | $2.8 | 1,672 | 07-03-2024 |
$2.8 | $2.84 | $2.8 | $2.855 | $2.78 | 44,634 | 07-02-2024 |
$2.85 | $2.84 | $2.85 | $2.9 | $2.84 | 15,860 | 07-01-2024 |
$2.91 | $2.95 | $2.91 | $2.9899 | $2.9 | 15,456 | 06-28-2024 |
$2.95 | $2.83 | $2.95 | $2.95 | $2.83 | 17,947 | 06-27-2024 |
$2.86 | $2.86 | $2.86 | $2.91 | $2.83 | 7,459 | 06-26-2024 |
$2.86 | $2.78 | $2.86 | $2.87 | $2.78 | 18,999 | 06-25-2024 |
$2.78 | $2.82 | $2.78 | $2.8724 | $2.78 | 15,257 | 06-24-2024 |
$2.86 | $2.7915 | $2.86 | $2.86 | $2.7915 | 8,146 | 06-21-2024 |
$2.84 | $2.82 | $2.84 | $2.8699 | $2.78 | 5,145 | 06-20-2024 |
News, Short Squeeze, Breakout and More Instantly...
-- Ongoing Phase 1 Study Evaluating Voruciclib Plus Venetoclax Demonstrates Anti-leukemic Activity, Including Complete Responses, Anticipated Decreases in Mcl-1 and No Overlapping Toxicity in Heavily Pretreated R/R AML Patients -- -- Board of Directors Unanimously Aligned on Prioritizatio...
– MEI Pharma Board Unanimously Determines, Based on Clinical Data Results, Not to Proceed with Second Capital Return Under 2023 Anson and Cable Car Cooperation Agreement: Conserving Capital, Prioritizing Measured Investment, Extending Operational Runway – MEI Pharma, Inc. ...